7-O-Arylmethylgalangin as a novel scaffold for anti-HCV agents (Q42924747)

11 November 2017

title

7-O-Arylmethylgalangin as a novel scaffold for anti-HCV agents (English)

1 reference

11 November 2017

2

Kwang-su Park

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797857

2 July 2024

5

Dong-Eun Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797857

2 July 2024

author name string

Hyo Seon Lee

1

1 reference

11 November 2017

Chaewoon Lee

3

1 reference

11 November 2017

Bokhui Lee

4

1 reference

11 November 2017

Youhoon Chong

6

1 reference

11 November 2017

language of work or name

English

0 references

publication date

6 August 2010

1 reference

full work available at URL

11 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0960894X10011224?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

https://api.elsevier.com/content/article/PII:S0960894X10011224?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Bioorganic & Medicinal Chemistry Letters

2 July 2024

published in

1 reference

11 November 2017

volume

20

1 reference

11 November 2017

issue

19

1 reference

11 November 2017

page(s)

5709-5712

1 reference

11 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.

2 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

The way forward in HCV treatment--finding the right path

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase.

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Antiviral drugs in current clinical use.

2 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Role of flavonoids and iron chelation in antioxidant action

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

The antioxidant properties of theaflavins and their gallate esters--radical scavengers or metal chelators?

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Bulletin de la Société Chimique de France

2 July 2024

17

II

125

Hauteville

1979

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Facile synthesis of flavonoid 7-O-glycosides

2 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

NS3 Peptide, a Novel Potent Hepatitis C Virus NS3 Helicase Inhibitor: Its Mechanism of Action and Antiviral Activity in the Replicon System

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.08.012

2 July 2024

Identifiers

1 reference

11 November 2017

1 reference